Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
Donald Husereau
1
,
Michael Drummond
2
,
Federico Augustovski
3, 4, 5
,
Esther de bekker-Grob
6
,
Andrew H. Briggs
7
,
Chris Carswell
8
,
Lisa Caulley
9, 10, 11
,
Nathorn Chaiyakunapruk
12
,
Dan Greenberg
13
,
Elizabeth Loder
14, 15
,
J A Mauskopf
16
,
C. Daniel Mullins
17
,
S. Petrou
18
,
Raoh Fang Pwu
19
,
Sophie H. Staniszewska
20
3
Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS- CONICET), Buenos Aires
|
5
CONICET (National Scientific and Technical Research Council), Buenos Aires, Argentina
|
8
Adis Journals, Springer Nature, Auckland, New Zealand
|
11
12
15
The BMJ, London, UK
|
16
RTI Health Solutions, RTI International, Research Triangle Park, NC, USA
|
19
National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei City, Taiwan
|
Publication type: Journal Article
Publication date: 2022-01-11
scimago Q1
wos Q1
SJR: 1.856
CiteScore: 8.0
Impact factor: 6.0
ISSN: 10983015, 15244733
PubMed ID:
35031088
Public Health, Environmental and Occupational Health
Health Policy
Abstract
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces the previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, and the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as healthcare, public health, education, and social care). This Explanation and Elaboration Report presents the new CHEERS 2022 28-item checklist with recommendations and explanation and examples for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer-reviewed journals and the peer reviewers and editors assessing them for publication. Nevertheless, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, given that there is an increasing emphasis on transparency in decision making.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
20
|
|
|
BMJ Open
19 publications, 3.45%
|
|
|
PharmacoEconomics
18 publications, 3.27%
|
|
|
Journal of Medical Economics
15 publications, 2.73%
|
|
|
Applied Health Economics and Health Policy
15 publications, 2.73%
|
|
|
Value in Health Regional Issues
15 publications, 2.73%
|
|
|
PLoS ONE
14 publications, 2.55%
|
|
|
Expert Review of Pharmacoeconomics and Outcomes Research
14 publications, 2.55%
|
|
|
JAMA network open
13 publications, 2.36%
|
|
|
PharmacoEconomics - Open
11 publications, 2%
|
|
|
Cost Effectiveness and Resource Allocation
11 publications, 2%
|
|
|
Value in Health
11 publications, 2%
|
|
|
BMC Public Health
7 publications, 1.27%
|
|
|
BMC Health Services Research
7 publications, 1.27%
|
|
|
Health Economics Review
7 publications, 1.27%
|
|
|
Frontiers in Pharmacology
5 publications, 0.91%
|
|
|
Advances in Therapy
5 publications, 0.91%
|
|
|
ClinicoEconomics and Outcomes Research
5 publications, 0.91%
|
|
|
Trials
4 publications, 0.73%
|
|
|
Frontiers in Public Health
4 publications, 0.73%
|
|
|
BMC Cancer
4 publications, 0.73%
|
|
|
The Lancet Global Health
4 publications, 0.73%
|
|
|
HRB Open Research
4 publications, 0.73%
|
|
|
International Journal of Environmental Research and Public Health
3 publications, 0.55%
|
|
|
Vaccines
3 publications, 0.55%
|
|
|
Human Vaccines and Immunotherapeutics
3 publications, 0.55%
|
|
|
Frontiers in Oncology
3 publications, 0.55%
|
|
|
Vaccine
3 publications, 0.55%
|
|
|
Journal of Medical Internet Research
3 publications, 0.55%
|
|
|
Therapeutic Advances in Gastroenterology
3 publications, 0.55%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
Publishers
|
20
40
60
80
100
120
140
160
180
|
|
|
Springer Nature
163 publications, 29.64%
|
|
|
Elsevier
99 publications, 18%
|
|
|
Taylor & Francis
43 publications, 7.82%
|
|
|
Wiley
35 publications, 6.36%
|
|
|
BMJ
29 publications, 5.27%
|
|
|
Frontiers Media S.A.
22 publications, 4%
|
|
|
Public Library of Science (PLoS)
20 publications, 3.64%
|
|
|
Cold Spring Harbor Laboratory
18 publications, 3.27%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
16 publications, 2.91%
|
|
|
American Medical Association (AMA)
16 publications, 2.91%
|
|
|
MDPI
15 publications, 2.73%
|
|
|
SAGE
14 publications, 2.55%
|
|
|
Oxford University Press
12 publications, 2.18%
|
|
|
JMIR Publications
7 publications, 1.27%
|
|
|
F1000 Research
6 publications, 1.09%
|
|
|
Cambridge University Press
4 publications, 0.73%
|
|
|
American Society of Hematology
2 publications, 0.36%
|
|
|
American Thoracic Society
2 publications, 0.36%
|
|
|
Mary Ann Liebert
2 publications, 0.36%
|
|
|
S. Karger AG
2 publications, 0.36%
|
|
|
Universidade Federal de Santa Catarina
2 publications, 0.36%
|
|
|
Netherlands Society of Cardiology
1 publication, 0.18%
|
|
|
Harborside Press, LLC
1 publication, 0.18%
|
|
|
American College of Physicians
1 publication, 0.18%
|
|
|
Mark Allen Group
1 publication, 0.18%
|
|
|
Massachusetts Medical Society
1 publication, 0.18%
|
|
|
Royal College of Psychiatrists
1 publication, 0.18%
|
|
|
Japanese Society for Pharmacoepidemiology
1 publication, 0.18%
|
|
|
Ubiquity Press
1 publication, 0.18%
|
|
|
20
40
60
80
100
120
140
160
180
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
551
Total citations:
551
Citations from 2024:
343
(62.36%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Husereau D. et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force // Value in Health. 2022. Vol. 25. No. 1. pp. 10-31.
GOST all authors (up to 50)
Copy
Husereau D., Drummond M., Augustovski F., de bekker-Grob E., Briggs A. H., Carswell C., Caulley L., Chaiyakunapruk N., Greenberg D., Loder E., Mauskopf J. A., Mullins C. D., Petrou S., Pwu R. F., Staniszewska S. H. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force // Value in Health. 2022. Vol. 25. No. 1. pp. 10-31.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.jval.2021.10.008
UR - https://doi.org/10.1016/j.jval.2021.10.008
TI - Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
T2 - Value in Health
AU - Husereau, Donald
AU - Drummond, Michael
AU - Augustovski, Federico
AU - de bekker-Grob, Esther
AU - Briggs, Andrew H.
AU - Carswell, Chris
AU - Caulley, Lisa
AU - Chaiyakunapruk, Nathorn
AU - Greenberg, Dan
AU - Loder, Elizabeth
AU - Mauskopf, J A
AU - Mullins, C. Daniel
AU - Petrou, S.
AU - Pwu, Raoh Fang
AU - Staniszewska, Sophie H.
PY - 2022
DA - 2022/01/11
PB - Elsevier
SP - 10-31
IS - 1
VL - 25
PMID - 35031088
SN - 1098-3015
SN - 1524-4733
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Husereau,
author = {Donald Husereau and Michael Drummond and Federico Augustovski and Esther de bekker-Grob and Andrew H. Briggs and Chris Carswell and Lisa Caulley and Nathorn Chaiyakunapruk and Dan Greenberg and Elizabeth Loder and J A Mauskopf and C. Daniel Mullins and S. Petrou and Raoh Fang Pwu and Sophie H. Staniszewska},
title = {Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force},
journal = {Value in Health},
year = {2022},
volume = {25},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/j.jval.2021.10.008},
number = {1},
pages = {10--31},
doi = {10.1016/j.jval.2021.10.008}
}
Cite this
MLA
Copy
Husereau, Don, et al. “Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.” Value in Health, vol. 25, no. 1, Jan. 2022, pp. 10-31. https://doi.org/10.1016/j.jval.2021.10.008.
Profiles